Covishield

	Breakthrough infection with Delta, reinfection with Omicron in individual vaccinated with Covishield The findings of the study prove the immune evasion potential of the Omicron variant, even after infection and vaccination, said the researchers. published on : 24th April 2022
	Serum Institute to give free Covishield vials to private vaccination centres to compensate for price difference India began administering the precaution dose of COVID-19 vaccines to all beneficiaries aged above 18 years at private vaccination centres from Sunday. published on : 10th April 2022
	Covishield & Covaxin prices cut, hospitals to pay Rs 225 per dose The precautionary dose has to be of the same vaccine used for the first two doses. published on : 10th April 2022
	Serum Institute, Bharat Biotech cut COVID vaccine prices for private hospitals to Rs 225 The Union Health Ministry on Friday announced that those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose. published on : 9th April 2022
	Kerala post-graduate student dies after taking Covishield; parents move HC seeking justice Nova was taken to a hospital where she was given symptomatic treatment for headache and fever. She was treated in casualty with Dolo IV injection and Emeset 2ml injection and was discharged later. published on : 8th April 2022
	Serum Institute's Covishield precaution dose priced at Rs 600 per shot The Union Health Ministry on Friday announced that those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose. published on : 8th April 2022
	Low number of COVID-19 cases now as India chose right vaccine, says Poonawalla Speaking to reporters on the sidelines of the 'Alternate Fuel Conclave', he said the fourth wave, if at all it occurs, will hopefully be mild. published on : 4th April 2022
	Booster dose of COVID vaccine needed to fight against Omicron: Study The study involved three cohorts -- a heterologous group with 18 individuals who were inadvertently administered the first dose of Covishield and the second dose of Covaxin in Uttar Pradesh. published on : 2nd April 2022
	Second Covishield dose can be given between 8-16 weeks after first: NTAGI The NTAGI has not yet suggested any change in the schedule of Bharat Biotech's Covaxin, whose second dose is administered 28 days after the first dose. published on : 20th March 2022
	Third-wave effect: Vaccine stocks reach expiry date Low demand for Covid vaccines; hospitals giving booster shots to staffers to cut down wastage published on : 21st February 2022
	Will mixing of Covishield, Covaxin work? trial results by February-end Conducted by Christian Medical College (CMC), Vellore, the study will also test the effectiveness of heterologous vaccine doses against new Covid variants. published on : 16th February 2022
	142,55,22,208 Covishield doses, 23,85,86,688 Covaxin doses administered till February 3, Rajya Sabha told Bharati Pravin Pawar said according to the RGI, the estimated population of beneficiaries in the age group of 15-18 years is 7.4 crores for 2021-22. published on : 8th February 2022
	SII urges Mandaviya to reduce gap between 2nd, precaution dose of Covishield from 9 to 3 months This will help to control unpredictable and fast spread of various strains of COVID-19, claimed the Pune-based firm. published on : 4th February 2022
	Media reports claiming 50 Lakh unused Covishield doses may go waste by month end 'misleading': Government It said the Centre had proactively advised all state governments to review the availability of vaccines, right from the start of the vaccination drive against COVID-19. published on : 3rd February 2022
	Regular market approval granted for Covishield, Covaxin for use in adult population The price of the two vaccines are likely to be capped at Rs 275 per dose, reports said. An additional service charge of Rs 150 will be added. published on : 27th January 2022